Editor Note: For more information about this release, please scroll to bottom.
LONDON, May 1, 2014 /PRNewswire/ --
The U.S. stock markets on Tuesday, April 29, 2014 ended on a positive note as the Dow Jones Industrial Average finished at 16,535.37, up 0.53% and the NASDAQ Composite closed at 4,103.54, up 0.72%. The S&P 500 finished the session 0.48% higher at 1,878.33. During the trading session, eight out of ten sectors finished on a higher note. Investor-Edge looks at some of the equities that hit a new 52-week high during the last session. These include Banco Santander S.A. (NYSE: SAN), Merck & Co. Inc. (NYSE: MRK), Schlumberger Ltd (NYSE: SLB) and Orbital Sciences Corp. (NYSE: ORB). Free technical research on SAN, MRK, SLB and ORB can be downloaded upon signing up at:
Shares in Banco Santander S.A. ended the day at $9.82, up 0.20%, hitting a new 52-week high of $10.00. A total of 10.72 million shares were traded, which was above its three months average volume of 5.10 million shares. The stock moved between $9.80 and $10.00 during the session. Over the last one month and the previous three months, Banco Santander S.A.'s shares have advanced 4.58% and 12.74%, respectively. Moreover, since the beginning of 2014, the company's stock has gained an upside of 8.27%. The S&P 500 Financials Sector Index mapped a gain of 0.95% during the session and the index has advanced 4.30% in the previous three months. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $9.34 is greater than its 200-day moving average of $8.55. The company's stock has a Relative Strength Index (RSI) of 58.42. Sign up today to read free research on SAN at:
On Tuesday, Merck & Co. Inc.'s stock oscillated between $57.27 and $58.86, hitting a new 52-week high of $58.86. Shares in the company surged 3.60% to end the session at $58.72. The company's stock reported a trading volume of 13.49 million shares, above its three months average volume of 11.85 million shares. Shares of the company traded at a PE ratio of 16.87. Merck & Co. Inc.'s shares have gained 2.07% in the previous three trading sessions, 4.89% in the last one month, and 17.32% on YTD basis. The S&P 500 Health Care Sector Index registered a gain of 0.62% during the session, while the index has advanced 0.52% in the last one month. Merck & Co. Inc.'s stock is trading above its 50-day and 200-day moving averages of $56.25 and $50.67, respectively. Moreover, shares of the company have an RSI of 52.22. On the same day, Merck & Co. Inc. announced its Q1 2014 financial results. For Q1 2014, the company reported Non-GAAP net income attributable to Merck & Co. Inc. of $2.60 billion, or $0.88 per diluted share. Sign up today to read free research on MRK at:
Schlumberger Ltd's stock edged 0.10% higher on Tuesday, finishing the day at $101.39, hitting a new 52-week high of $103.58. The stock recorded a trading volume of 6.97 million shares, which is above its three months average volume of 6.12 million shares. The stock oscillated between $101.34 and $103.58 during the trading session. Over the past one month and previous three months, Schlumberger Ltd's shares have gained 3.92% and 16.14%, respectively. Further, the stock has advanced 12.52% since the start of this year. The S&P 500 Energy Sector Index recorded a gain of 0.42% during the session and the index has surged 10.94% in the previous three months. The stock is trading above its 50-day and 200-day moving averages. Schlumberger Ltd's 50-day moving average of $95.09 is above its 200-day moving average of $89.25. Additionally, the stock traded at a PE ratio of 20.28 and has an RSI of 65.85. Sign up today to read free research on SLB at:
On Tuesday, Orbital Sciences Corp.'s stock rallied 16.52%, closing the day at $30.96, after hitting a new 52-week high of $34.16. The stock recorded a trading volume of 4.02 million shares, which is above its three month average volume of 0.36 million shares. Shares of the company traded at a PE ratio of 29.21. Orbital Sciences Corp.'s shares have surged 12.26% in the previous three trading sessions, 13.95% in the last one month, and 32.88% on YTD basis. The S&P 500 Industrials Sector Index edged 0.25% higher during the session, while the index has gained 5.60% in the previous three months. Orbital Sciences Corp.'s stock is trading above its 50-day and 200-day moving averages of $27.69 and $23.22, respectively. Furthermore, shares of the company have an RSI of 45.92. On the same day, Orbital Sciences Corp. announced a definitive agreement with Alliant Techsystems Inc. (ATK), which will combine the company and ATK's Aerospace and Defense Groups in $5 Billion Merger-of-Equals to Create "Orbital ATK." Sign up today to read free research on ORB at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.